OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 54 filers reported holding OYSTER PT PHARMA INC in Q4 2022. The put-call ratio across all filers is 4.81 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,191 | -99.8% | 554,288 | -1.9% | 0.06% | +80.0% |
| Q3 2022 | $3,174,000 | +57.8% | 564,856 | +21.6% | 0.04% | +59.1% |
| Q2 2022 | $2,011,000 | -62.0% | 464,383 | +2.2% | 0.02% | -53.2% |
| Q1 2022 | $5,287,000 | -21.9% | 454,167 | +22.5% | 0.05% | -17.5% |
| Q4 2021 | $6,771,000 | +47.0% | 370,784 | -4.6% | 0.06% | +39.0% |
| Q3 2021 | $4,606,000 | -32.0% | 388,730 | -1.4% | 0.04% | -30.5% |
| Q2 2021 | $6,777,000 | -7.8% | 394,213 | -2.0% | 0.06% | -13.2% |
| Q1 2021 | $7,354,000 | +11.4% | 402,283 | +14.6% | 0.07% | -1.4% |
| Q4 2020 | $6,604,000 | +10.7% | 350,926 | +24.1% | 0.07% | -11.5% |
| Q3 2020 | $5,968,000 | +32.9% | 282,707 | +81.9% | 0.08% | +23.8% |
| Q2 2020 | $4,489,000 | – | 155,433 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 2,768,586 | $32,226,000 | 14.34% |
| Paradigm Biocapital Advisors LP | 987,698 | $11,497,000 | 3.04% |
| NEA Management Company, LLC | 5,925,287 | $68,970,000 | 1.99% |
| KPCB XIV Associates, LLC | 367,987 | $4,283,000 | 1.61% |
| Telemark Asset Management, LLC | 787,026 | $9,161,000 | 0.81% |
| COWEN AND COMPANY, LLC | 509,794 | $5,934,000 | 0.57% |
| RTW INVESTMENTS, LP | 2,058,504 | $23,961,000 | 0.50% |
| ACT CAPITAL MANAGEMENT, LLC | 13,500 | $157,000 | 0.17% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $12,101,000 | 0.11% |
| Wildcat Capital Management, LLC | 36,847 | $429,000 | 0.11% |